Nancy Dohse Hanson, PhD

Department

Med. Microbiology & Immunology

Position

Professor

Books

• Multidrug Resistance A Global Concern
  Khalaf N. G., The Scope of Bacterial Resistance to Antibiotics in some Countries in the Middle East and North Africa [Book Chapter] 2012

Articles

• Torres María P., A multiplex real-time PCR assay for identification of multi-drug resistant Gram-negative pathogens 2016

Publications

• The Journal of infectious diseases
  Maclean Alyssa K W, What Contributes to the MIC? Beyond β-Lactamase Gene Detection in Klebsiella pneumoniae 2024
• Maclean Alyssa K.W., Intrapatient transfer of an uncommon carbapenemase in Nebraska 2022
• Mack Andrew R., A standard numbering scheme for class c β-lactamases 2021
• Journal of Antimicrobial Chemotherapy
  Suelter Corey S., OmpC regulation differs between ST131 and non-ST131 Escherichia coli clinical isolates and involves differential expression of the small RNA MicC
  75:5, p. 1151 - 1158 2020
• Antimicrobial agents and chemotherapy
  Mack Andrew R., A standard numbering scheme for class C β-lactamases
  64:3 2020
• MicrobiologyOpen
  Harrison Lucas B., lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosa
  8:11 2019
• Microbiology Resource Announcements
  Harrison Lucas B., Draft genome assemblies of clinical isolates of klebsiella pneumoniae V9011662 and enterobacter hormaechei Entb306
  8:15 2019
• Genome Announcements
  Harrison Lucas B., Draft genome sequence of the mucoid Pseudomonas aeruginosa clinical isolate PA34
  5:46 2017
• Antimicrobial Agents and Chemotherapy
  Harrison Lucas, High Resolution Melting Analysis for the Rapid Detection of Sequence Type 131 Escherichia Coli
  61:6 2017
• Diagnostic Microbiology and Infectious Disease
  Bork Jacqueline T., Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae 2017
• BioTechniques
  Connelly Christopher M., Plasmid-mediated β-lactamases
  61:5, p. 272 - 275 2016
• Antimicrobial Agents and Chemotherapy
  Dixon Nyssa, IMP-27, a Unique Metallo-Beta-Lactamase Identified in Geographically Distinct Isolates of Proteus Mirabilis
  60:10, p. 6418 - 6421 2016
• Antimicrobial Agents and Chemotherapy
  Furuyama T., Structural and Mutagenic Analysis of Metallo-Beta-Lactamase IMP-18
  60:9, p. 5521 - 5526 2016
• The Journal of Antimicrobial Chemotherapy
  Geyer Chelsie N., Evaluation of CTX-M steady-state mRNA, mRNA half-life and protein production in various STs of Escherichia coli
  71:3, p. 607 - 616 2016
• Microbiologyopen
  Fowler Randal C., The OpdQ porin of Pseudomonas aeruginosa is regulated by environmental signals associated with cystic fibrosis including nitrate-induced regulation involving the NarXL two-component system
  4:6, p. 967 - 982 2015
• Journal of Clinical Microbiology
  Ledeboer N. A., Identification of Gram-Negative Bacteria and Genetic Resistance Determinants from Positive Blood Culture Broths using the Verigene Gram-Negative Blood Culture Multiplex Microarray-Based Molecular Assay
  53:8, p. 2460 - 2472 2015
• Biotechniques
  Connelly C. M., Antibiotic Resistance Monitoring and Detection (Arm-d™) Pcr Kits: Arm-d™ for β-Lactamase Id – Technical Note: Detection of Esbls, Mbls, Kpcs, and Plasmid-Mediated Ampcs, using the β-Lactamase Id Kit to Identify Antibiotic Resistance in Gram-Negative Patho
  57:6, p. 317 - 318 2014
• BioTechniques
  Connelly Christopher M., Philisa® ampC ID Kit – Technical Note
  57:4, p. 214 - 215 2014
• Journal of Clinical Microbiology
  Geyer Chelsie N., Multiplex high-resolution melting analysis as a diagnostic tool for detection of plasmid-mediated AmpC ??-lactamase genes
  52:4, p. 1262 - 1265 2014
• PLoS One
  Fowler Randal C., Emergence of Carbapenem Resistance Due to the Novel Insertion Sequence ISPa8 in Pseudomonas aeruginosa
  9:3, p. e91299 2014
• Diagnostic microbiology and infectious disease
  Fowler Randal C., Whole Genome Mapping of the First Reported Case of KPC-2-positive Klebsiella pneumoniae ST258 in Nebraska
  79:3, p. 384 - 386 2014
• Journal of Antimicrobial Chemotherapy
  Roth Amanda L., Effect of drug treatment options on the mobility and expression of blaKPC
  68:12, p. 2779 - 2785 2013
• Acta Crystallographica Section F: Structural Biology and Crystallization Communications
  Furuyama Takamitsu, Purification, crystallization and preliminary X-ray analysis of IMP-18, a class B carbapenemase from Pseudomonas aeruginosa
  69:12, p. 1397 - 1400 2013
• Biotechniques
  Geyer Chelsie N., Rapid Screening of Transformants using the Streck Philisa® Thermal Cycler
  55:5, p. 274 2013
• Hanson Nancy D., Resistance in Gram-negative Pathogens 2013
• PLoS pathogens
  Hu Guoku, Release of Luminal Exosomes Contributes to TLR4-Mediated Epithelial Antimicrobial Defense
  9:4 2013
• Diagnostic Microbiology and Infectious Disease
  Geyer Chelsie N., Rapid PCR amplification protocols decrease the turn-around time for detection of antibiotic resistance genes in Gram-negative pathogens
  77:2, p. 113 - 117 2013
• Journal of Clinical Microbiology
  Roth A. L., Rapid Detection and Statistical Differentiation of KPC Gene Variants in Gram-negative Pathogens Using High Resolution Melting and ScreenClust Analysis
  51:1, p. 61 - 65 2013
• Journal of clinical microbiology
  Geyer Chelsie N., Development of a TaqMan multiplex PCR assay for detection of plasmid-mediated AmpC β-lactamase genes
  50:11, p. 3722 - 3725 2012
• Antimicrobial agents and chemotherapy
  Johnson James R., Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and bla CTX-M-15among extended-spectrum-β- lactamase-producing E. coli from the United States, 2000 to 2009
  56:5, p. 2364 - 2370 2012
• Journal of Antimicrobial Chemotherapy
  Kurpiel Philip M., Point mutations in the inc antisense RNA gene are associated with increased plasmid copy number, expression of blaCMY-2 and resistance to piperacillin/tazobactam in Escherichia coli
  67:2, p. 339 - 345 2012
• Journal of Clinical Microbiology
  Roth A. L., Production of KPC-2 Alone Does Not Always Result in Resistant beta-lactam MICs in Gram-negative Pathogens
  50:12, p. 4183 - 4184 2012
• Epidemiology research international
  Robledo Iraida E., Dissemination and Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Collected in Puerto Rico Medical Center Hospitals during a 1-Year Period
  2011, p. 1 - 8 2011
• Clinical Neurophysiology
  Powell D., Enhancement of parkinsonian rigidity with contralateral hand activation
  122:8, p. 1595 - 1601 2011
• Antimicrobial Agents and Chemotherapy
  Roth Amanda L., blaKPC RNA Expression Correlates with Two Transcriptional Start Sites but Not Always with Gene Copy Number in Four Genera of Gram-negative Pathogens
  55:8, p. 3936 - 3938 2011
• Journal of Antimicrobial Chemotherapy
  Kurpiel Philip M., Association of IS5 with divergent tandem blaCMY-2 genes in clinical isolates of Escherichia coli
  66:8, p. 1734 - 1738 2011
• Antimicrobial agents and chemotherapy
  Borgianni Luisa, Genetic context and biochemical characterization of the IMP-18 metallo-β-lactamase identified in a Pseudomonas aeruginosa isolate from the United States
  55:1, p. 140 - 145 2011
• Microbe
  Hanson Nancy D., Molecular diagnostics could help in coping with hidden β-lactamases
  5:8, p. 333 - 339 2010
• Munier G. K., Positive extended-spectrum-β-lactamase (ESBL) screening results may be due to AmpC β-lactamases more often than to ESBLs 2010
• AbdelGhani Sameh M.M., First report of CTX-M-14 -producing clinical isolates of Salmonella serovar Typhimurium from Egypt 2010
• Clinical Microbiology Reviews
  Lister Philip D., Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms
  22:4, p. 582 - 610 2009
• Journal of Antimicrobial Chemotherapy
  Wolter Daniel J., Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype
  64:2, p. 294 - 300 2009
• BMC Infectious Diseases
  Khalaf Noha G., Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt
  9 2009
• Antimicrobial Agents and Chemotherapy
  Wolter Daniel J., Surveillance of Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Puerto Rican Medical Center Hospitals: Dissemination of KPC and IMP-18 beta-Lactamases
  53:4, p. 1660 - 1664 2009
• Antimicrobial agents and chemotherapy
  Wolter Daniel J., Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4
  53:2, p. 557 - 562 2009
• Antimicrobial Agents and Chemotherapy
  Schmidtke Amber J., Role of ampD Homologs in Overproduction of AmpC in Clinical Isolates of Pseudomonas aeruginosa
  52:11, p. 3922 - 3927 2008
• Antimicrobial Agents and Chemotherapy
  Hanson Nancy D., Surveillance of community-based reservoirs reveals the presence of CTX-M, imported AmpC, and OXA-30 beta-lactamases in urine isolates of Klebsiella pneumoniae and Escherichia coli in a US community
  52:10, p. 3814 - 3816 2008
• Clinical Infectious Diseases
  Wolter Daniel J., Emergence of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from a Patient with Cystic Fibrosis in the Absence of Carbapenem Therapy
  46:12, p. e137 - e141 2008
• Antimicrobial agents and chemotherapy
  Wolter Daniel J., Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin
  51:8, p. 2997 - 3000 2007
• Diagnostic Microbiology and Infectious Disease
  Netzel Tisha C., The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum β-lactamases in Escherichia coli
  58:3, p. 345 - 348 2007
• Antimicrobial Agents and Chemotherapy
  Hong S. G., In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci
  51:4, p. 1512 - 1514 2007
• Journal of Medical Microbiology
  Sidjabat Hanna E., Identification of plasmid-mediated extended-spectrum and AmpC β-lactamases in Enterobacter spp. isolated from dogs
  56:3, p. 426 - 434 2007
• Moland Ellen Smith, Klebsiella pneumoniae isolate producing at least eight different β-lactamases, including AmpC and KPC β-lactamases [1] 2007
• Journal of Antimicrobial Chemotherapy
  Wickman P. A., In vitro development of resistance to DX-619 and other quinolones in enterococci
  58:6, p. 1268 - 1273 2006
• Journal of Clinical Microbiology
  Moland E. S., Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002
  44:9, p. 3318 - 3324 2006
• Journal of Medical Microbiology
  Sidjabat Hanna E., Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia
  55:8, p. 1125 - 1134 2006
• Antimicrobial Agents and Chemotherapy
  Schmidtke A. J., Model system to evaluate the effect of ampD mutations on AmpC-mediated beta-lactam resistance
  50:6, p. 2030 - 2037 2006
• Hanson Nancy D., First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18 [3] 2006
• Journal of Antimicrobial Chemotherapy
  Sidjabat Hanna E., Identification of blaCMY-7 and associated plasmid-mediated resistance genes in multidrug-resistant Escherichia coli isolated from dogs at a veterinary teaching hospital in Australia
  57:5, p. 840 - 848 2006
• Antimicrobial Agents and Chemotherapy
  Wolter D. J., AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump
  49:11, p. 4763 - 4766 2005
• Journal of Clinical Microbiology
  Song W., Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia
  43:9, p. 4891 - 4894 2005
• Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  Hong Tao, Escherichia coli
  40:10, p. e84 - 86 2005
• Mortensen Joel E., New quality control strain for use in routine testing for production of extended-spectrum beta-lactamases by Enterobacteriaceae [1] 2005
• Journal of clinical microbiology
  Pitout Johann D.D., Phenotypic and molecular detection of CTX-M-β-lactamases produced by Escherichia coli and Klebsiella spp.
  42:12, p. 5715 - 5721 2004
• Antimicrobial Agents and Chemotherapy
  Reisbig Mark D., Promoter sequences necessary for high-level expression of the plasmid-associated ampC beta-lactamase gene bla(MIR-1)
  48:11, p. 4177 - 4182 2004
• Antimicrobial Agents and Chemotherapy
  Hossain Ashfaque, Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp.
  48:11, p. 4438 - 4440 2004
• Antimicrobial Agents and Chemotherapy
  Abdalhamid Baha, Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada
  48:11, p. 4435 - 4437 2004
• Journal of clinical microbiology
  Liebana Ernesto, Pediatric infection due to multiresistant Salmonella enterica serotype infantis in Honduras
  42:10, p. 4885 - 4888 2004
• Diagnostic Microbiology and Infectious Disease
  Wolter Daniel J., Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital
  50:1, p. 43 - 50 2004
• FEMS Microbiology Letters
  Wolter Daniel J., Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance
  236:1, p. 137 - 143 2004
• Clinical Infectious Diseases
  Pitout Johann D.D., Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum β-Lactamases
  38:12, p. 1736 - 1741 2004
• Journal of Antimicrobial Chemotherapy
  Hossain Ashfaque, Plasmid-encoded functions compensate for the biological cost of AmpC overexpression in a clinical isolate of Salmonella typhimurium
  53:6, p. 964 - 970 2004
• Microbial Drug Resistance
  Liebana Ernesto, Characterization of β-Lactamases Responsible for Resistance to Extended-Spectrum Cephalosporins in Escherichia coli and Salmonella enterica Strains from Food-Producing Animals in the United Kingdom
  10:1, p. 1 - 9 2004
• Journal of clinical microbiology
  Pitout Johann D.D., Association between handling of pet treats and infection with Salmonella enterica serotype Newport expressing the AmpC β-lactamase, CMY-2
  41:10, p. 4578 - 4582 2003
• Journal of clinical microbiology
  Pitout J. D.D., Modification of the double-disk test for detection of Enterobacteriaceae producing extended-spectrum and AmpC β-lactamases
  41:8, p. 3933 - 3935 2003
• Journal of Antimicrobial Chemotherapy
  Hanson Nancy D., AmpC β-lactamases
  52:1, p. 2 - 4 2003
• Moland E. Smith, Discovery of CTX-M-like extended-spectrum β-lactamases in Escherichia coli isolates from five U.S. States [2] 2003
• Journal of Antimicrobial Chemotherapy
  Reisbig Mark D., Factors influencing gene expression and resistance for Gram-negative organisms expressing plasmid-encoded ampC genes of Enterobacter origin
  51:5, p. 1141 - 1151 2003
• Journal of Antimicrobial Chemotherapy
  Mahlen Steven D., Analyses of ampC gene expression in Serratia marcescens reveal new regulatory properties
  51:4, p. 791 - 802 2003
• Journal of Antimicrobial Chemotherapy
  Moland Ellen Smith, Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates
  51:3, p. 711 - 714 2003
• Journal of clinical microbiology
  Coudron Philip E., Occurrence of extended-spectrum and ampC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae
  41:2, p. 772 - 777 2003
• Antimicrobial agents and chemotherapy
  Moland Ellen Smith, Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 U.S. Hospitals
  46:12, p. 3837 - 3842 2002
• Journal of clinical microbiology
  Pérez-Pérez F. Javier, Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR
  40:6, p. 2153 - 2162 2002
• Journal of Antimicrobial Chemotherapy
  Hanson Nancy D., Unusual Salmonella enterica serotype Typhimurium isolate producing CMY-7, SHV-9 and OXA-30 β-lactamases
  49:6, p. 1011 - 1014 2002
• Journal of Antimicrobial Chemotherapy
  Reisbig Mark D., The ACT-1 plasmid-encoded AmpC β-lactamase is inducible
  49:3, p. 557 - 560 2002
• Diagnostic Microbiology and Infectious Disease
  Hanson Nancy D., Enzymatic characterization of TEM-63, a TEM-type extended spectrum β-lactamase expressed in three different genera of Enterobacteriaceae from South Africa
  40:4, p. 199 - 201 2001
• ChemInform
  Hanson N. D., ChemInform Abstract: Regulation of Inducible AmpC β-Lactamase Expression Among Enterobacteriaceae
  31:6, p. no - no 2000
• Current Pharmaceutical Design
  Hanson N. D., Regulation of inducible AmpC beta-lactamase expression among enterobacteriaceae
  5:11, p. 881 - 894 1999
• Journal of Antimicrobial Chemotherapy
  Hanson Nancy D., Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpC
  44:3, p. 377 - 380 1999
• Antimicrobial agents and chemotherapy
  Pitout J. D.D., β-lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia colt, and Proteus mirabills isolates recovered in South Africa
  42:6, p. 1350 - 1354 1998
• Antimicrobial agents and chemotherapy
  Pitout Johann D.D., Plasmid-mediated resistance to expanded-spectrum cephalosporins among Enterobacter aerogenes strains
  42:3, p. 596 - 600 1998
• Virus Research
  Hanson Nancy, The herpes simplex virus type 2 gene which encodes the large subunit of ribonucleotide reductase has unusual regulatory properties
  34:3, p. 265 - 280 1994
• Virology
  Bratanich Ana C., The latency-related gene of bovine herpesvirus 1 inhibits the activity of immediate-early transcription unit 1
  191:2, p. 988 - 991 1992
• Journal of Virology
  Hanson N. D., Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification
  65:8, p. 4325 - 4333 1991
• Experimental Mycology
  Hanson Nancy Dohse, Membrane protein variation in Dictyostelium mucoroides during sorocarp and macrocyst development
  11:4, p. 354 - 359 1987

Presentations

• ASM Distinguished Lecturer: The Regulation of β-Lactamase ProductionHow many variations can there be? 2016
• American Society for Microbiology Distinguished Lecturer Program: Baltimore MD Molecular Diagnostics: Current and Future Applications for Detection of Antibiotic Resistance Mechanisms 2016
• November 7, 2015: Invited Symposium Speaker for the Association for Molecular Pathologists. Title of the talk: Molecular Detection of β-Lactamase Genes: Why and How? 2015
• October 7, 2015. Invited Lecturer selected by the graduate students at K-State University. Title of the talk: Molecular Detection of β-Lactamase Genes: The Human/Animal Connection 2015
• September 26, 2015. Dr. Hanson gave the American Society Distinguished Lecture for the joint meeting for the Kentucky/Tennessee Branch of the American Society of Microbiology. Title of the talk: The Global Explosion of Gram-negative β-lactamase Producers: What can be done? 2015
• September 24, 2015. Dr. Hanson gave a seminar to the Biology Department at Middle Tennessee State University. Title of the talk: The Regulation of β-Lactamase Production: How many variations can there be? 2015
• Interscience Conference on Antimicrobial Agents and Chemotherapy. title: 7-plex and 10-plex PCR assays for the detection of ampC, blaCTX-M, and 5 carbapenemase genes using rapid PCR amplification. 2015
• 7-plex and 10-plex PCR assays for the detection of ampCs, blaCTX-Ms, and 5 carbapenemase genes using rapid PCR amplification. 2015 In Abstracts of the 115th American Society of Microbiology. New Orleans, LA. 2015
• KPC translational efficiency differs between sequence type 131 (ST131) and non-ST 131 E. coli. L.B. Harrison, Y. Doi, N.D. Hanson. 2015 In Abstracts of the 115th American Society of Microbiology. New Orleans, LA. Poster Presentation. 2015
• Development of an eighteen-minute multiplex PCR assay for the simultaneous detection of 6 OXA carbapenemases. R.C. Fowler and N. D. Hanson. 2015 In Abstracts of the 115th American Society of Microbiology. New Orleans, LA. Poster Presentation. 2015
• American Society of Microbiology Distinguished Lecturer: Regulation of Beta-lactamase production: How many variations can there be? Northern California ASM Branch Meeting. 2015
• American Society of Microbiology Distinguished Lecturer: Global Explosion of Gram‐Negative β‐lactamase Producers: What can be done? Northern California ASM Branch Meeting. 2015
• Gram-Negative Innovation Day: "Learn & Imagine The Global Explosion of Gram‐Negative β‐lactamase Producers: What can be done?" Lexington, MA. Sponsored by Cubist 2014
• One 22-minute multiplx assay for the detection of 9 targets including ampCs, ESBLs, MBLs, and KPCs using Rapid PCR Amplification. N.D. Hanson Speaker. In Abstracts of the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC. Sponsored by Streck. 2014
• 1. The Rapid Detection of ampC Resistance Genes in Gram-negative Bacteria. N.D. Hanson Speaker. In Abstracts of the 114th American Society of Microbiology. Boston MA. Sponsored by Streck. 2014
• Identification of Promoter Sequences required for the Expression of the Porin Gene opdQ of Pseudomonas aeruginosa. Randal Fowler and N. D. Hanson. 2014. In Abstracts of the 114th American Society of Microbiology. Boston MA. Poster Presentation. 2014
• Overproduction of the Porin OpdQ is Associated but not Responsible for Multidrug Supersusceptibility (SS) in Carbapenem-selected Mutants of Pseudomonas aeruginosa (PA). R. Fowler and N. D. Hanson. 2014. In Abstracts of the 114th American Society of Microbiology. Boston MA. Poster Presentation. 2014
• One sixteen minute multiplex assay for the detection of AmpCs, ESBLs, MBLs and KPCs using Rapid PCR Amplification. C. Geyer, S. Morrow, and, N. Hanson. 2014. In Abstracts of the 24th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spa 2014
• The Discordant Relationship Between CTX-M-15 mRNA and Protein Production does not Interfere With Beta-Lactam/Beta-Lactamase Inhibitor Combination Susceptibilities in Escherichia coli. C.Geyer, R. Fowler, and N. Hanson. 2014. In Abstracts of the 24th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain. 2014
• The mRNA half-life of CTX-M-15 transcripts is controlled by a factor encoded on the blaCTX-M-15 containing plasmid. C. Geyer, and N. Hanson. 2014. In Abstracts of the 24th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona, Spain. 2014
• Gram-negative Summit: Gram-negative Multi-Drug Resistant Mechanisms. June 18, 2013. Boston MA. Sponsored by Cubist. 2013
• 1. Rapid Detectin of KPC Gene Variants in Gram-negative Pathogens Using High-Resolution Melting and ScreenClust Analyses. N.D. Hanson Speaker. In Abstracts of the 115th American Society of Microbiology. Denver CO. Sponsored by Qiagen. 2013
• Identification of family-specific plasmid-mediated AmpC β-lactamase (pmAmpC) genes using multiplex PCR and High Resolution Melth (HRM) Analysis. C. N. Geyer and N. D. Hanson. 2013. In Abstracts of the 113th American Society of Microbiology. Denver CO. Poster Presentation. 2013
• 1. Carbapenem resistance is not associated with virulence of Pseudomonas aeruginosa using the Dictyostelium discoideum virulence model. R. Fowler, A.T. Weber, and N. D. Hanson. 2012. In Abstracts of the 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA Poster Presentation. 2012
• High resolution melting analysis allows rapid detection and differentiation of blaKPC alleles in Gram-ngative pathogens. A. L. Roth, M. Kovarik, and N.D. Hanson. 2012. In Abstracts of the 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. Poster Presentation. 2012
• Evaluation of blaCTXM14 and blaCTXM15 Identifies Differential Gene Expression Among Sequence Type 131 and Non-ST131 E. coli. C. N. Geyer, S. Weissman, P. Hawkey and N. D. Hanson. 2012. In Abstracts of the 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. Poster Presentation. 2012
• Kinetic Characterization of a novel VIM (VIM-28) Metallo--lactamase in Pseudomonas aeruginosa isolates from Egypt. A. Yoshizumi, Y. Ishii, T.S.El-Mahdy, N. D. Hanson, and K. Tateda. 2012. In Abstracts of the 52th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA. Poster Presentation. 2012
• HudsonAlpha Institute. Huntsville, Alabama. Institutional Seminar Speaker. August 9, 2012. Title: "The Impact of Molecular Testing to Control the Antibiotic Resistance Crisis Caused by Gram-Negative Pathogens" 2012
• Symposium Talk for the Regional American Society of Microbiology Meetngs in Kansas City. "Mobile Genetic Elements Associated with Beta-Lactam Resistance 2006
• Amber Schmidtke and Nancy D Hanson. Molecular Characterization of the ampD promoter of Pseudomonas aeruginosa. Oral presentation 2006
• Efflux Pump and Porin Alterations in a Supersuceptible (SS) Strain of P. aeruginosa (PA). D. J. Wolter, J. A. Black, P. D. Lister, N. D. Hanson. 2005. In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. Poster presentation 2005
• Phenotypic Reversion of Imipenem Hypersusceptibility among mexCD-oprJ-Oeverexpressing P. aeruginosa: a complex system becomes more complex. 2005. D. J. Wolter, N. D. Hanson, P.D. Lister. In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. Oral Presentation 2005
• In Vitro Development of Resistance to DX-619 (DX) and Other Quinolones (Qs) in Enterococcus faecium. P. Wickman, J. A. Black, E. Smith Moland, K. S. Thomson, and N. D. Hanson. 2005. In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. Poster Presentation 2005
• A Novel Mechanism of AmpD-Mediated Derepression in an Isolate of Citrobacter freundii. A. J. Schmidtke and N.D. Hanson. 2005 In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. Oral presentation 2005
• Correlation of ampC Induction with PBP Binding in Enterobacter cloacae. B. Abdalhamid, P. A. Wickman, and N. D. Hanson. 2005 In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. oral presentation 2005
• Apparent Acquisition of ESBL Leading to Treatment Failure during Cefepime (FEP) Therapy of Klebsiella pneumoniae (KP) Bacteremia. W. Song, E. Smith Moland, N. D. Hanson, J. S. Lewis, J. H. Jorgensen, and K. S. Thomson. 2005. In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C Poster Presentation 2005
• Invited Symposium Speaker: American Society of Microbiology 45th Interscience Conference on Antimicrobial Agents and Chemotherapy: Washington DC, USA: December 2005. "Detection of Extended Spectrum -lactamases and Plasmid-mediated AmpC -lactamases Using Phenotypic and Molecular Tests. 2005
• OXA-30-Like -lactamases in E. coli Hydrolyze Cefepime. E. S. Moland, N. D. Hanson, C. Shubert, K. S. Thomson. 2005. In Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. Poster presentation 2005
• Society for General Microbiology, Edinburgh, Scotland. Symposium Lecture April 2004. Title: Molecular Mechanisms of AmpC Gene Expression and the Clinical Implications Associated with Gram-negative Pathogens. 2005
• A community-wide outbreak of clonally related Escherichia coli producing CTX-M-type -lactamases in the Calgary Health Region (CHR).2004. J. D. D. Pitout, D. B. Gregson, D. L. Church, K. B. Laupland, S. Elsayed, and N. D. Hanson. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Klebsiella isolates that Co-produce ESBL and inducible DHA-like plasmid-mediated AmpC beta-lactamases from Baltimore, MD and Tampa, FL. Black, J.A., E.S. Moland, A. Hossain, J.A. Johnson, M. Campbell, T.J. Lockhart, L.B. Olson, K. S. Thomson, and N. D. Hanson. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Occurrence of Proteus mirabilis producing FOX-5 plasmid-mediated AmpC beta-lactamase in USA. Black, J.A., E.S. Moland, A. Hossain, G.A. Denys, , T.J. Lockhart, L.B. Olson, K. S. Thomson, and N. D. Hanson. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Increased Expression of ampC in Pseudomonas aeruginosa mutants following exposure to ciprofloxacin (CIP). D. J. Wolter, N.D. Hanson, and P.D.Lister. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Beta-lactam MICs and differential expression of blaCMY-2 reflect dual promoter activity. M.D. Reisbig and N.D. Hanson. 2004. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Comparison of ampC transcript half-life among three genera of Enterobacteriaceae. B. Abdalhalmid and N. D. Hanson. 2004. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Development of a Model System to Determine the Effect of ampD mutations on -lactam Resistance. 2004. A. J. Schmidtke and N.D. Hanson. In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• The First Occurrence of a Pseudomonas aeruginosa in the United States (US) Producing and IMP Metallo--lactamase (MBL). N.D.Hanson, A. Hossain, L. Buck, E.S. Moland, and K.S. Thomson. 2004 In Abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C. 2004
• Australian Society of Microbiology Antimicrobial Meeting, Queensland Regional Meeting. Morton Bay Research Facility, North Stradbroke Island, Brisbane Australia. July 2004. World Wide Emergence of Beta-lactam Resistance: The Need for Molecular Diagnostics. 2004
• University of Queensland, Brisbane, Australia: Department of Veterinary Science. July 2004. The Molecular Mechanisms Involved in AmpC-Mediated Resistance: A Complex Process. 2004
• Australian Society of Microbiology Antimicrobial Meeting, Grand Rounds: Womens and Childrens Hospital, Adelaide, Australia: July 2004. ESBLs and AmpCs: Whats the Difference? 2004
• Australian Society of Microbiology Antimicrobial Meeting, Grand Rounds: Concord Hospital, Sydney Australia: July 2004. ESBLs and Plasmid-mediated AmpC in Gram-Negative Bacteria- What are the differences? 2004
• Survey of cefoxitin (FOX) non-wusceptible (NS) E. coli urine isolates (UIs) reveals a high incidence of plasmid-encoded AmpC (pAmpC) -Lactamase (L) Producers. 2004. M.D. Reisbig, S.J. Cavalieri, H.A. Hashish, R.V. Goering, and N.D. Hanson. In Abstracts of the 104th General Meeting of the American Society for Microbiology. New Orleans, LA. 2004
• 18. Laboratory Diagnosis of Escherichia coli and Klebsiella spp. producing CTX-M--lactamases. 2004. J. D. D. Pitout, A. Hossain, D. L. Church, N. D. Hanson. In Abstracts of the 104th General Meeting of the American Society for Microbiology. New Orleans, LA. 2004
• Paediatric infection due to multi-resistant Salmonella Infantis carrying blaCMY-2, blaTEM-1, blaCTX-M-15 and blaSHV-5 -lactamases. 2004. E. Liebana, J. Martinez-Urtaza, M. Batchelor, C. Torres, L. Brinas, L.A. Lagos, B. Abdalhamid, N.D. Nanson, F.A. Clifton-Hadley, R.H. Davies. In Abstracts of the 104th General Meeting of the American Society for Microbiology. New Orleans, LA. 2004
• 16. Evaluation of cefepime (FEP) with and without clavulanic acid (CA) for the detection of ESBLs (Extended Spectrum Beta-Lactamases) in Enterobacteriaceae species. 2004. E. Smith Moland, T.J. Lockkhart, J.A. Black, L.B. Olson, A. HOssain, N.D. Hanson, and K.S. Thomson. In Clinical Microbiology and Infection. 14th European Congress of Clinical Microbiology and Infectious Diseases. 2004
• Abdalhamid, B. and N. D. Hanson. Differential half-life of the ampC transcript between three genera of Enterobacteriaceae. April 2004. In Abstracts of the Regional American Society for Microbiology, Missouri Valley Branch. Kansas City, Missouri. 2004
• Schmidtke, A. and N. D. Hanson. AmpD mutations in E. coli. April 2004. In Abstracts of the Regional American Society for Microbiology, Missouri Valley Branch. Kansas City, Missouri. 2004
• Puerto Rico Veterans Administration Hospital: Infectious Disease Fellows: February 2004. World Wide Emergence of -lactam and Fluoroquinolone Resistance: The Need for Molecular Diagnostics. 2004
• University of Puerto Rico, Department of Microbiology and Medical Zoology Graduate Seminar: February 2004. The Complexities of Molecular Mechanisms Involved in AmpC-Mediated Resistance. 2004
• University of Puerto Rico School of Medicine: Grand Rounds. February 2004. World Wide Emergence of -lactam and Fluoroquinolone Resistance: The Need for Molecular Diagnostics. 2004
• Childrens Hospital, Grand Rounds. January 2004. Evolution of Antibiotic Resistance and the Concomitant Decrease in Therapeutic Options for Lung Infections in the Cystic Fibrosis Patient. 2004
• Emergence of Fluoroquinolone (FQ) Resistant Pseudomonas aeruginosa (PA) in a Cystic Fibrosis (CF) Patient: Discordance between MexEF-OprN and Carbapenem Susceptibility. 2003. D.J. Wolters, J. Black, D. Acquazzino, R. Goering, P.Sammut, N. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. Oral Presentation 2003
• Molecular Analysis of 10 Putative Efflux Genes in Streptococcus pneumoniae (SP) Reveals Widespread Differences Between Wildtype (WT) Strains and Multi-Drug Resistant (MDR) Clinical Isolates. 2003. P.A. Wichman, K.S. Thomson, N.D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. Oral Presentation 2003
• A Novel Mechanism of Resistance to Ciprofloxacin (CIP) and Ethidium Bromide (EB) in Streptococcus pneumoniae (SP): Downregulation of a Putative Permease. 2003. P.A. Wichman, G. A. Perry, K.S. Thomson, N. D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. Oral Presentation 2003
• Insertional Inactivation of oprD in Clinical Isolates of Pseudomonas aeruginosa Leading to Carbapenem Resistance. 2003. D.J. Wolter, N. Hanson, P. Lister. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. Oral Presentation 2003
• Prevalence of Plasmid-mediated AmpC beta-lactamases in Klebsiella pneumoniae (KP), Klebsiella oxytoca (KO), Proteus mirabilis (PM), and Salmonella (S) Isolates from 42 ICU and 21 non-ICU Sites in the United States. 2003 J.A. Black, E.Smith Moland, A. Hossain, T.J. Lockhard, L.B. Olson, K.S. Thomson, N.D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• Deletional Analysis of the blaMir-1 Upstream Region Reveals a Novel Promoter Necessary for High-Level Expression and beta-Lactam Resistance. 2003. M. D. Reisbig and N. D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois 2003
• Citrobacter freundii from Canada Producing A Novel CTX-M Gene, blaCTX-M-30. 2003. A. Abdalhamid, J.D.D. Pitout, N.D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• Surveillance for Escherichia coli Producing CTX-M-Type -Lactamases in the Calgary Health Region (CHR). 2003. J.D.D. Pitout, K.B. Laupland, D.L. Church, S. Elsayed, D. Gregson, N.D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• Detection of CTX-M-Like ESBLs in Thirteen States within the USA. 2003. E.S. Moland, J.A. Black, K.S. Thomson, N.D. Hanson, T. J. Lockhart, L.B. Olson, A. Hossain. 2003
• Characterisation of Beta-lactamases Responsible for Resistance to Extended-Spectrum Cephalosporins in E. coli and S. enterica from U.K. Food Animals. 2003. E. Liebana, M. Gibbs, C. Clouting, L. Barker, F. Clifton-Hadley, E. Pleydell, B. Abdalhamid, N. Hanson, L. Martin, C. Poppe, R. Davies. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• E. coli producing KPC-3 carbapenem hydrolyzing enzyme (CHE). 2003. T. Hong, E.S. Moland, B. Abdalhamid, N.D. Hanson, J. Wang, C. Sloan, D. Fabian, A. Farajallah, J. Levine, K.S. Thomson. 2003. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• Prevalence of ESBLs in the United States. 2003. E. Smith Moland, J.A. Black, N.D. Hanson, A. Hossain, B. Abdalhamid, W. Song, T.J. Lockhart, L.B. Olson, K.S. Thomson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• Occurrence of a CTX-M-1-like ESBL in a U.S. Isolate of Citrobacter freundii (CF). 2003. S.E. Sharp, C. Suarez, E. Smith Moland, A. Hossain, N.D. Hanson, and K.S. Thomson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• A New Quality Control Strain for Routine Testing for Production of Extended Spectrum Beta-Lactamases (ESBL). 2003. J.E. Mortensen, M. Bernier, L. Gray, S. Doland, E.S. Moland, B. Abdalhamid, N.D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• First Report of Plasmid-encoded (PE) Carbapenem Hydrolyzing Enzyme (CHE) KPC-2 in Enterobacter cloacae (EC). 2003 A. Hossain, M.J. Ferraro, R.M. Pino, R.B. Dew III, E.S. Moland, T.J. Lochart, K.S. Thomson, R.V. Goering, and N.D. Hanson. In Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2003
• A. Hossain, Reisbig. M.D., and N.D. Hanson. High-level expression of the plasmid-encoded AmpC gene, blaCMY-7 does not compromise the virulent phenotype of a strain of Salmonella typhimurium. In Abtracts of the 13th European Congress of Clinical Microbiology and Infectious Disease, Glasgow, United Kingdom 2003
• M.D. Reisbig and N.D. Hanson. Variations in -Lactam Susceptibilities Between Organisms Expressing the Plasmid-Encoded AmpC beta-lactamase CMY-2 is Attributed to Variable Gene Expression. In Abstracts of the 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, United Kingdom 2003
• Daniel J. Wolter, Nancy D. Hanson, and Philip D. Lister. Multi-Drug Resistance Associated with mexXY Expression in Clinical Isolates of Pseudomonas aeruginosa from a Texas Hospital. In Abstracts of the 13th Congress of Clinicacl Microbiology and Infectious Diseases, Glasgow, United Kingdom 2003
• A. Hossain. P. Wickman, K. S. Thomson and N.D. Hanson Molecular analysis of Streptococcus pneumoniae mutants selected by DK-507k, an investigational fluoroquinolone. In Abstracts of the 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, United Kingdom 2003
• D WOLTER, M. REISBIG, N. HANSON, P. LISTER. Pharmacodynamics of Cefepime-Aztreonam Combination against Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients. In Abstracts of the 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, United Kingdom 2003
• P.A. Wickman*, A. Hossain, K.S. Thomson, and N.D. Hanson Differences in selection of efflux-mediated fluoroquinolone resistance in penicillin-susceptible and -resistant Streptococcus pneumoniae after repeated exposure to ciprofloxacin and moxifloxacin. In Abstracts of the 13th European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, United Kingdom. 2003
• Oklahoma State University: Stillwater Oklahoma. October 28, 2002. The Complexities of Molecular Mechanisms Involved in AmpC Beta-lactamase-mediated Resistance 2002
• Discovery of CTX-M-like ESBLs in E. coli Isolates from Five States in the USA. 2002. E. Smith Moland, S. Pottumarthy-Boddu, J.A. Black, A. Hossain, N.D. Hanson, K.S. Thomson. In Abstracts Addendum of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA. 2002
• Pitout, J.D., E.Smith-Moland, S. Elsayed, N. Hamilton, J. Conly, D. Church, N. Hanson. 2002. A Novel Carbapenem-Hydrolyzing Enzyme (CHE) Produced by an Enterobacter cloacae Isolate from Canada. In Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA. 2002
• Wolter, D. J., N.D. Hanson, and P. D. Lister. 2002. Continued Expression of mexCD-oprJ Among Phenotypic Revertants of Pseudomonas aeruginosa (PA) that Have Lost Their Fluoroquinolone Resistance. In Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA. 2002
• Wolter, D. J., T. J. Lockhart, N.D. Hanson, and P.D. Lister. 2002. Imipenem Hypersusceptibility Among mexCD-oprJ Hyperexpressing Mutants of Pseudomonas aeruginosa does not Involve Decreased expression of ampC or Increased Expression of oprD. In Abstracts of the 42nd Interscience 2002
• Hossain, A., E.S. Moland, J.A. Black, N.D. Hanson, K.S. Thomson. 2002. DQ-113: In Vitro development and Mutational Analysis of Resistance in Staphylococcus aureus, Penicillin Resistant Streptococcus pneumoniae (PRSP) and Vancomycin Resistant Enterococci (VRE). In Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA. 2002
• Reisbig, M.D. and N.D. Hanson. 2002. Therapeutic Implications for the Plasmid-Encoded (PE) AmpC beta-Lactamase, ACT-1, Expressed in ampD- E. coli. In Abstracts of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA. 2002
• University of Kansas, St. Lukes Hospital. October 15, 2002. ESBLs and AmpC Beta-lactamases: What's the Difference 2002
• ESBLs and AmpC beta-lactamases: Whats the Difference? 1. Irish Society of Clinical Microbiology: Dublin Ireland Invited Speaker 2002
• Great Plains State Society for Molecular Biology and Genetics: Omaha, Nebraska: June 2002. Invited speaker "AmpC-mediated resistance in Gram-negative bacteria: Questions but not many answers." 2002
• American Society of Microbiology Symposium Speaker: Salt Lake City, Utah, USA: May 2002. "AmpC beta-Lactamases: A Conundrum." 2002
• Wolter, D.J., N.D. Hanson, G. Haynatzki, and P.D. Lister. 2002. Efflux-Mediated Resistance Among Pseudomonas aeruginosa: Complex Regulation of a Complex Resistance Mechanism. In Abstracts of the 102nd General Meeting of the American Society for Microbiology. Salt Lake City, Utah. 2002
• Reisbig, M.D. and N.D. Hanson. 2002. The Role of Gene Copy Number in Overall Expression of ampC Genes of Enterobacter cloacae Origin. The 102nd General Meeting of the American Society for Microbiology. Salt Lake City, Utah. 2002
• Morrow, S.S. and N.D. Hanson. 2002. Differentiation of Multiple SHV or FOX Genes Using Denaturing High Performance Liquid Chromatography. 2002. In Abstracts of the 102nd General Meeting of the American Society for Microbiology. Salt Lake City, Utah. 2002
• Wickman, P.A., A. Hossain, K.S. Thomson, and N.D. Hanson. 2002. Moxifloxacin has Reduced Potential to Select Mutational Fluoroquinolone Resistance in Streptococcus pneumoniae. In Abstracts of the 102nd General Meeting of the American Society for Microbiology. Salt Lake City, Utah. 2002
• Moland, E.S., K.K. Sandu, M.R. Pincus, J.A. Black, M.D. Reisbig, N.D. Hanson, K.S. Thomson. 2002. A Simple Phenotypic Approach to the Detection of Inducible Plasmid-mediated AmpC -lactamse (pAmpC) Production in Two New York Isolated of Klebsiella pneumoniae (KP). In Abstracts of the 102nd General Meeting of the American Society for Microbiology. Salt Lake City, Utah. 2002
• Moland, E.S., J. Johnson, J.A. Black, T.J. Lockhart, A. Hossain, V.L. Herrera, R.V. Goering, N.D. Hanson, and K.S. Thomson. 2001. Klebsiella pneumoniae (KP) Isolates Producing a Carbapenem Hydrolyzing Enzyme (CHE). In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Coudron, P.E., S.M. Tallent, E.S. Moland, N.D. Hanson, M.B. Edmond, R.P. Wenzel. 2001. Occurrence of Extended-Spectrum (ESBL) and AmpC Beta-Lactamases (BLs) in U.S. Bacteremic Isolates of Klebsiella pneumoniae (Kp): Two Isolates Harbor Inducible Plasmid-Mediated ACT-1-Like BLs. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Moland, E.S., T.J. Cleary, M.D. Reisbig, Y. Jiang, P.E. Coudron, T.J. Lockhart, N.D. Hanson, K.S. Thomson. 2001. Occurrence of Inducible Plasmid-mediated AmpC -lactamase (ipAmpC), DHA-1, in a Miami Isolate of Klebsiella pneumoniae: New Implications for Susceptibility Testing? In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Hossain, A., E.S. Moland, J.A. Black, S.A. Chartrand, N.D. Hanson, K.S. Thomson. 2001. A New Fluoroquinolone (FQ) With a Low Frequency of Mutational Resistance in MRSA. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Herrera, V.L. and N.D. Hanson. 2001. Complex Expression of Novel Plasmid-mediated AmpC -Lactamase Gene. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois.Chicago, Illinois. 2001
• Jiang, Y., E.S. Moland, Y.Ni, N.D. Hanson. 2001. Novel Mutations in the Promoter and Attenuator Regions of Hyperproducing AmpC E. coli strains from China. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Hanson, N.D., S.A. Neville, I.B. Gosbell, A. Hossain, E.S. Moland, and K.S. Thomson. 2001. Salmonella enterica serotype Typhimurium producing CMY-7, SHV-9 and OXA-30 -Lactamases. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Reisbig, M.D. and N.D. Hanson. 2001. The Plasmid-mediated AmpC -Lactamase, ACT-1, is Inducible in a Multiply Resistant Klebsiella pneumoniae Isolate. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. 2001
• Mahlen, S.D. and N.D. Hanson. 2001. The Stem-Loop Structure in the 5Untranslated Region (5UTR) of the ampC Transcript of Serratia marcescens is Involved in Transcript Stability. In Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago, Illinois. Oral Presentation given by N.D. Hanson. 2001
• American Society for Microbiology Regional Meeting. Analysis of the 5' flanking region of a novel plasmid-mediated amp'c beta-lactamase 2001
• American Society of Microbiology Regional Meeting. Deletion of secondary structure in the 5' untranslated region of the ampC gene of Serratia marcescens results in a decrease in translational efficiency 2001
• American Society for Microbiology Regional Meeting. Inverse relationship in the expression of multi-drug efflux pumps 2001
• American Society for Microbiology Regional Meeting. Molecular and phenotypic analysis to determine the influence of moxifoxacin and ciprofloxacin in selecting mutational fluoroquinolone resistance in Streptococcus pneumoniae 2001
• American Society for Microbiology Regional Meeting. PCR amplification of the genetically diverse ampC genes of Enterobacter cloacae using the proof-reading enzyme, Pwo 2001
• American Society for Microbiology Regional Meeting. The plasmid-mediated AmpC beta-lactamase, ACT-1, is inducible 2001
• Regional Medical Student Research Forum. Evaluation of Nucleotide Diversity within Pseudomonas aeruginosa ampC beta-lactamase 2001
• University of Nebraska at Lincoln.Graduate Seminar Speaker."The regulation of AmpC Beta-lactamase expression in Enterobacteriaceae." 2001
• Regional AAAS meeting. Analysis of the 5' flanking region of the plasmid-mediated ampC gene, ACT-1 reveals an Enterobacter clacae ampR binding sight and an ampR gene. 2000
• University of Dublin, Trinity College, Ireland: Annual molecular medicine symposium, Keynote speaker microbial genetics. Title: "The regulation of AmpC Beta-lactamase expression in Enterobacteriaceae." 2000
• Medical School of Edinburgh, Scotland "The regulation of AmpC B-Lactamase expression in Enterobacteriaceae and its relationship to resistance." 2000
• St. James Hospital, Dublin, Ireland"The regulation of AmpC B-Lactamase expression in Enterobacteriaceae and its relationship to resistance." 2000
• University of Nebraska at Omaha.Graduate Seminar Speaker."The regulation of AmpC Beta-lactamase expression in Enterobacteriaceae." 2000
• 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. toronto Canada. A Novel Growth-Phase Dependent Factor that Binds to the Serratia marcescens ampC gene and correlates with a Decrease in ampC Transcription 2000
• Identification, Cloning and Sequencing of a Novel FOX Plasmid-Mediaated AmpC, N.D. Hanson, P. Coudron, E.S. Moland and C.C. Sanders 39th ICAAC. San Francisco 1999
• Sequence Analysis of the ampC and ampR Regions of Serratia marcescens Reveals a Unique 5' Untranslated Region in ampC. S.S. Morrow, C.C. Sanders, and N.D. Hanson 39th ICAAC San Francisco, 1999
• Molecular Characterization of Mutants Responsible for Dichotomous Fluoroquinolone Resistance in Staphlococcus aureus, 39th ICAAC, San Francisco 1999
• Detection and Characterization of the Beta-Lactamases Produced by Citrobacter koseri, ES Moland, KS Thomson, C.C. Sanders, N.D. Hanson, 39th ICACCA San Francisco 1999
• Differential Induction of the Chromosomal Beta-Lactamase Gene of Seratia marcescens by beta-Lactam Antibiotics, Missouri Valley Regional ASM, Tulsa, OK; 1999
• Cloning and sequencing of the chromosomally encoded ampC and ampR genes of Serratia marcescens, Missouri Valley Regional ASM, Tulsa, OK, 1999
• Transcriptional analysis of Serratia marcescens ampC, Mahlen, S.D. C.C. Sanders, and N.D. Hanson,Southwestern and Rocky Mountain Division American Association for the Advancement of Science, Creighton University, Omaha, NE 1999

Other

• Technical Service Agreement: Microorganism Growth and Inactivation

• Evaluation of Chromosomal Mechanisms Contributing to Imipenem-Relebactam Non-Susceptibility in Pseudomonas aeruginosa and K. pneumoniae Clinical Isolates

• Cobas vivoDx CRE Early Customer Feedback Protocol with Isolates

• Evaluation of Cifiderocol Susceptibility Profiles for Beta-Lactamase Producing Enterobacteriaceae and Carbapenem Resistant Pseudomonas Aeruginosa

• Development of a PCR-based Screening Tool for the Identification of Oral Bacteria Associated with Hard to Detect Digestive Cancers

• Development of Molecular Tools and a Mouse Model of Urinary Tract Infections to Evaluate Infectivity of Physiologically Characterized Strains of the Pandemic E. coli Clone, Sequence Type 131

• Evaluating the Association Between the Expression of 65533 -lactamase Enzymes and Other Proteins and Antimicrobial Resistance (AMR) in Gram-Negative Bacterial Pathogens

• A Prospective & Retrospective Multi-Center US Clinical Trial for Evaluating the Performance of the Antibiotics Within the GP21 Drug Round Vitek 2

• Research Compliance Regulatory Support

• B3150 - 2021 BPE Additional Testing

• VITEK(R) 2 and VITEK(R) 2 Compact Lefamulin Antimicrobial Susceptibility Test

• BioMerieux - B3150 - Cefotaxime Additional Testing

• 2023 Piperacillin/Tazobactam-PRG0028/3150

• Technical Service Agreement: Microorganism Growth and Inactivation

• Evaluation of Chromosomal Mechanisms Contributing to Imipenem-Relebactam Non-Susceptibility in Pseudomonas aeruginosa and K. pneumoniae Clinical Isolates

• Cobas vivoDx CRE Early Customer Feedback Protocol with Isolates

• Evaluation of Cifiderocol Susceptibility Profiles for Beta-Lactamase Producing Enterobacteriaceae and Carbapenem Resistant Pseudomonas Aeruginosa

• Development of a PCR-based Screening Tool for the Identification of Oral Bacteria Associated with Hard to Detect Digestive Cancers

• Development of Molecular Tools and a Mouse Model of Urinary Tract Infections to Evaluate Infectivity of Physiologically Characterized Strains of the Pandemic E. coli Clone, Sequence Type 131

• Evaluating the Association Between the Expression of 65533 -lactamase Enzymes and Other Proteins and Antimicrobial Resistance (AMR) in Gram-Negative Bacterial Pathogens

• A Prospective & Retrospective Multi-Center US Clinical Trial for Evaluating the Performance of the Antibiotics Within the GP21 Drug Round Vitek 2

• Research Compliance Regulatory Support

• B3150 - 2021 BPE Additional Testing

• VITEK(R) 2 and VITEK(R) 2 Compact Lefamulin Antimicrobial Susceptibility Test

• BioMerieux - B3150 - Cefotaxime Additional Testing

• 2023 Piperacillin/Tazobactam-PRG0028/3150

Awards

• Outstanding service as a Branch Councilor
  American Society for Microbiology Outstanding service as a Branch Councilor of the Missouri Valley Branch
  American Society for Microbiology
• Received a one month travel award for the promotion of research to the University of Queensland, Brisbane Australia.
  Received a one month travel award for the promotion of research to the University of Queensland, Brisbane Australia.